- |||||||||| ziprasidone / Generic mfg.
Journal: Inhibition of VMAT2 by β2-adrenergic agonists, antagonists, and the atypical antipsychotic ziprasidone. (Pubmed Central) - Nov 24, 2022 Further, plausible binding modes of the established VMAT2 inhibitors reserpine and tetrabenazine and hit compounds salmeterol and ziprasidone were identified using molecular dynamics simulations and functional assays using VMAT2 wild-type and mutants. Our findings show VMAT2 as a potential off-target of treatments with several approved drugs in use today and can also provide important first steps in both drug repurposing and therapy development targeting VMAT2 function.
- |||||||||| aripiprazole / Generic mfg., ziprasidone / Generic mfg., clozapine / Generic mfg.
Retrospective data, Journal: Antipsychotics and Medical Comorbidity: A Retrospective Study in an Urban Outpatient Psychiatry Clinic. (Pubmed Central) - Nov 16, 2022 Two antipsychotics that are considered weight neutral, ziprasidone and aripiprazole, were associated with cardiometabolic comorbidities. This study suggests that research is warranted to study the association between antipsychotics, medical comorbidity, and psychotic symptom burden.
- |||||||||| ziprasidone / Generic mfg.
Preclinical, Journal: In vitro degradation of ziprasidone in human whole blood. (Pubmed Central) - Oct 22, 2022 Data from two postmortem investigations were available for retrospective reanalysis. Attempts were made to detect degradation products of ziprasidone, but none were found.
- |||||||||| Know Your CYPs! Meaningful Cytochrome p450 Interactions in the Treatment of Psychosis () - Oct 19, 2022 - Abstract #AACAP2022AACAP_286;
Some CYP1A2 substrates include olanzapine, clozapine, propranolol, and caffeine...Conclusions Many medications prescribed for patients experiencing early psychosis have important cytochrome p450 interactions. Knowledge of these interactions is important for providers at all levels.
- |||||||||| Vraylar (cariprazine) / Mitsubishi Tanabe, Recordati, Gedeon Richter, AbbVie
Retrospective data, Review, Journal: Variability and efficacy in treatment effects on manic symptoms with lithium, anticonvulsants, and antipsychotics in acute bipolar mania: A systematic review and meta-analysis. (Pubmed Central) - Oct 18, 2022 We demonstrated that eight antimanic drugs were associated with lower variability and better efficacy than placebo, suggesting that these antimanic drugs were associated with more homogenous and predictable improvements of manic symptoms in patients with acute mania. The study was supported by from the Ministry of Science and Technology (MOST-110-2314-B-016-035, MOST-111-2314-B-016-054), Medical Affairs Bureau (MND-MAB-D-111102), and Tri-service General Hospital (TSGH-E-111229).
- |||||||||| Risperdal Consta (risperidone depot formulation) / J&J
Metabolic syndrome among patients receiving long-active injectable antipsychotics: an observational retrospective study (Poster area [ONLINE]) - Oct 13, 2022 - Abstract #ECNP2022ECNP_1391; Some meta-analytic studies revealed that individuals treated with olanzapine had significantly higher insulin resistance index (IRI), fasting blood glucose (FBG), and fasting insulin (FINS) levels than those treated with aripiprazole, ziprasidone, or risperidone [2]...In addition, it is highlighted that the abdominal perimeter is high in both groups of patients (first and second generation antipsychotics). Finally, the practical implications are discussed, are analyzed and the main limitations are exposed., future lines of research are analyzed and the main limitations of the study that arise from the significant metabolic alterations that derive from the multitemporal injection of long-acting neuroleptics are exposed These initial Conclusion s will allow us to design future comparative studies between the different presentations of long-acting neuroleptics, to establish the profile of that product whose incidence of metabolic alterations is lower and thus be able to establish protocols of use appropriate to the characteristics of each patient. Keywords: Schizophrenia; Long-Active Injectable Antipsychotics; Metabolic syndrome; Psychotic Disorders
- |||||||||| Risperdal Consta (risperidone depot formulation) / J&J
Second-generation antipsychotics during pregnancy: what is new? (Poster area [IN-PERSON]) - Oct 13, 2022 - Abstract #ECNP2022ECNP_917; In case it is necessary to change therapy, aripiprazole is a good option. Both risperidone and paliperidone should be used with caution and never as first line.
- |||||||||| Prolactin as a mediator of functional outcome in first episode psychosis patients (Poster area [IN-PERSON]) - Oct 13, 2022 - Abstract #ECNP2022ECNP_680;
The clinical implication of this association is of great transcendence as it suggests that FEP male patients with negative symptomatology and hyperprolactinemia could benefit from AP treatment that has no effect on prolactin (aripiprazole and clozapine), or AP that cause an increase in prolactin to abnormal levels in <50% of patients (Quetiapine, Olanzapine, Ziprasidone) with the intention to improve their functional outcome. As far as we know, this is the first study to describe this association and suggest a better treatment option for this particular group of patients.
- |||||||||| ziprasidone / Generic mfg., clozapine / Generic mfg.
Effects of clozapine and ziprasidone in rats trained to discriminate between 22 and 2 hours food deprivation (SDCC Halls B-H) - Oct 10, 2022 - Abstract #Neuroscience2022NEUROSCIENCE_8907; Ziprasidone (1.0 mg/kg) reduced rates of lever pressing in most subjects and did not significantly affect food intake. These data further support for the notion that clozapine decreases feeding-related behaviors in rats and indicates atypical antipsychotic medications may have differential effects on food-related behaviors in rats.
- |||||||||| Vraylar (cariprazine) / Mitsubishi Tanabe, Recordati, Gedeon Richter, AbbVie, Rexulti (brexpiprazole) / Lundbeck, Otsuka
Retrospective data, Review, Journal: Efficacy and acceptability of second-generation antipsychotics with antidepressants in unipolar depression augmentation: a systematic review and network meta-analysis. (Pubmed Central) - Sep 29, 2022 Regarding efficacy, response rates indicated that all antipsychotics except for ziprasidone were more efficacious than the placebo, with the odds ratios (ORs) ranging from 1.34 for olanzapine and cariprazine [95% credible interval (CrI) 1.04-1.73 and 1.07-1.67, respectively] to 2.17 for risperidone (95% CrI 1.38-3.42)...For acceptability, quetiapine (OR 0.68, 95% CrI 0.50-0.91), brexpiprazole (OR 0.69, 95% CrI 0.55-0.86), and cariprazine (OR 0.61, 95% CrI 0.46-0.82) were worse than the placebo...The administration of adjunctive antipsychotics is associated with high effectiveness and low acceptability. Risperidone and aripiprazole are more efficacious and accepted than other atypical antipsychotics.
- |||||||||| fentanyl citrate / Generic mfg., ziprasidone / Generic mfg.
Journal: A false positive fentanyl result on urine drug screen in a patient treated with ziprasidone. (Pubmed Central) - Sep 14, 2022 Due to structural similarities, ziprasidone may also cause this same result. As clinicians become more aware of the ubiquity of fentanyl in the illicit drug supply, it is imperative that clinicians also consider limitations of the currently available UDSs.
- |||||||||| Journal: Comorbidities and the right dose: antipsychotics. (Pubmed Central) - Sep 14, 2022
Factors liable to impact antipsychotic dosage are numerous and their subsequent effects often hard to predict, due to multi-level interactions and compensatory phenomena. In clinical practice, physicians must be aware of these potential effects, but base their decisions on monitoring antipsychotic plasma levels.
- |||||||||| Vraylar (cariprazine) / Mitsubishi Tanabe, Recordati, Gedeon Richter, AbbVie
Retrospective data, Journal: A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years. (Pubmed Central) - Sep 7, 2022 Overall, tamoxifen appears to be the most effective of the currently known pharmaceutical therapy available to treat acute mania or manic episodes; however, this conclusion is restricted by the scale of RCTs conducted, and risperidone was found to be the most effective medication among antipsychotics. Carbamazepine, haloperidol, ziprasidone, cariprazine, olanzapine, quetiapine, aripiprazole, lithium, paliperidone, asenapine, and divalproex were noticeably effective in treating acute mania or manic episodes.
- |||||||||| Vraylar (cariprazine) / Mitsubishi Tanabe, Recordati, Gedeon Richter, AbbVie
Journal: Are antipsychotics effective adjunctive Tx for patients with moderate-to-severe depression? (Pubmed Central) - Aug 30, 2022 Augmenting antidepressant therapy with cariprazine, ziprasidone, or olanzapine also appears to improve depressive symptoms over the short term. All antipsychotics studied carried an increased likelihood of adverse effects that could lead to discontinuation (SOR: A, based on a systematic review of RCTs).
- |||||||||| Journal: QT shortening: a proarrhythmic safety surrogate measure or an inappropriate indicator of it? (Pubmed Central) - Aug 26, 2022
From a regulatory perspective one cannot refute the possibility of a clinically relevant risk from QT shortening through the current testing requirements. Lack of further investigations into any potential morphological changes to the AP, or APD shortening beyond a specified threshold in our opinion does not fully exclude the possibility of proarrhythmic effects of active substances.
- |||||||||| risperidone / Generic mfg., lurasidone / Generic mfg., ziprasidone / Generic mfg.
Journal: Investigations into the stability of 17 psychoactive drugs in a "simulated postmortem blood" model. (Pubmed Central) - Jul 17, 2022 However, the 1,2-benzisothiazole antipsychotics, ziprasidone and lurasidone, were found to degrade at a rate comparable to the known labile control, risperidone. In longer experiments (seven to twelve months), where specimens were stored at -20 °C, 4 °C, and ambient temperature, N-dealkylation degradation products were detected for many of the drugs, with greater formation in specimens stored at -20 °C than at 4 °C.
- |||||||||| Rexulti (brexpiprazole) / Lundbeck, Otsuka, Nuplazid (pimavanserin) / Acadia Pharma
Journal: Comparative Safety Signal Assessment of Hospitalization Associated With the Use of Atypical Antipsychotics. (Pubmed Central) - Jun 24, 2022 This cross-sectional assessment of data from FAERs (2004-2021) suggested that users of clozapine, olanzapine, quetiapine, risperidone, aripiprazole, and ziprasidone were more likely to report being hospitalized than users of other AAPs. Given that the FAERs database only contains spontaneous reports of AEs experienced by persons exposed to a drug but without information on exposed persons who did not have an event, a cohort study comparing hospitalizations among new users of individual AAPs against each other is needed to delineate these safety signals further.
- |||||||||| Invega Sustenna (paliperidone palmitate extended-release 1-month injection) / J&J
Journal: Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020. (Pubmed Central) - Jun 23, 2022 For example, there was a 3 to 4-fold increase in the prices of haloperidol, chlorpromazine, fluphenazine, trifluperazine and zuclopenthixol, while a less than two-fold increase in pimozide, flupenthixol, sulpiride, amisulpride and quetiapine and a decrease in the prices of clozapine, olanzapine, ziprasidone and risperidone in the tablet form...Consta 25, 37.5, 50 LAI 37.5/1 444.17 11.840 1/15* 29.61 10,807 5,402 16 Paliperidone Invega 3, 6, 9 tb 6/28 213.15 1.268 6 7.61 2,777 - Xeplion 50, 75, 100, 150 LAI 100/1 1161.56 11.615 1/30* 38.72 14,132 - Trevicta 175, 263, 350, 525 LAI 350/1 3426.95 9.788 1/90* 38.08 13,899 - 17 Aripiprazole Abilify 5, 10, 15, 20 tb; 1 sol 20/28 113.25 0.404 20 8.08 2,949 - Abilify Main...Table 2. Comparison of the Annual Costs of Antipsychotic Drugs Calculated By The Daily Standard Average Dose Use, at Certain Price Ranges, for the Years 2005 and 2020 Price bracket (TRY) 2005 2020 500 ↓ Haloperidol tb, amp, Trifluoperazine drj, Chlorpromazine tb, Pimozid tb, Fluphenazine LAI Haloperidol tb, amp, depo, Trifluoperazine drj, Pimozid tb 500-1,000 Flupenthixol drj, LAI, Zuklopenthixol tb, acu, LAI, Sulpirid tb Chlorpromazine tb, Fluphenazine LAI, Flupenthixol drj, LAI, Clozapine tb, Risperidone tb 1,000-2,000 Clozapine tb, Risperidone tb Olanzapine tb, Sulpirid tb 2,000-3,000 Amisulpirid tb, Olanzapine tb, Quetiapine tb Zuklopenthixol tb, acu, LAI, Amisulpirid tb, Ziprasidone tb, Paliperidone tb, Aripiprazole tb 3,000-5,000 Ziprasidone tb Quetiapine tb 5,000-10,000 Risperidone consta Sertindole tb 10,000 ↑ Risperidone consta, Paliperidone monthly, Paliperidone 3 monthly, Aripiprazole maintana tb: Tablet, drj: Dragee, amp: Ampoule, LAI: Long-acting injectable, acu: Acuphase.
- |||||||||| ziprasidone / Generic mfg.
Preclinical, Journal: Ziprasidone Induces Rabbit Atrium Arrhythmogenesis via Modification of Oxidative Stress and Sodium/Calcium Homeostasis. (Pubmed Central) - May 30, 2022 However, race and additional medications given during restraint were significantly associated with restraint duration. Our results suggest that ziprasidone increases the occurrence of atrial triggered activity and causes intracellular Ca and Na dysregulation, which may result from enhanced oxidative stress and activation of the TNF-α/NLRP3 inflammasome pathway in ziprasidone-treated myocytes.
- |||||||||| iloperidone / Generic mfg.
Retrospective data, Journal: Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants. (Pubmed Central) - May 8, 2022 "Moderate" confidence in the results was found for paliperidone-LAI 1-monthly, iloperidone-OS, fluphenazine-OS, brexpiprazole-OS, paliperidone-LAI 1-monthly, asenapine-OS, haloperidol-OS, quetiapine-OS, cariprazine-OS, and lurasidone-OS...This finding is of particular relevance for low- and middle-income countries and constrained-resource settings, where few medications may be selected. Results from this network meta-analysis can inform clinical guidelines and national and international drug regulation policies.
- |||||||||| Vraylar (cariprazine) / Mitsubishi Tanabe, Recordati, Gedeon Richter, AbbVie
Retrospective data, Review, Journal: Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials. (Pubmed Central) - May 6, 2022 In conclusions, these antipsychotics, carbamazepine, lithium, tamoxifen, and valproate were effective for acute mania. However, only aripiprazole, olanzapine, quetiapine, and risperidone had better acceptability than the placebo.
- |||||||||| Risperdal Consta (risperidone depot formulation) / J&J
PK/PD data, Journal: Model for Long Acting Injectables (Depot Formulation) Based on Pharmacokinetics and Physical Chemical Properties. (Pubmed Central) - May 6, 2022 The PK predictions for several drugs such as estradiol, risperidone, medroxyprogesterone acetate (MPA), and ziprasidone showed how these predictions can guide scientists to target specific depot doses and release rates into the depot formulation...The framework, prediction tools, and depot map will reduce the need for semi-empirical formulation work and preclinical studies to design depot formulations. Graphical Abstract.
- |||||||||| Vraylar (cariprazine) / Mitsubishi Tanabe, Recordati, Gedeon Richter, AbbVie, Rexulti (brexpiprazole) / Lundbeck, Otsuka
Retrospective data, Review, Journal: Efficacy and safety/tolerability of antipsychotics in the treatment of adult patients with major depressive disorder: a systematic review and meta-analysis. (Pubmed Central) - May 6, 2022 Recruitment has been initiated, and an update will be provided. Results suggest that there are significant differences regarding the risk/benefit ratio among antipsychotics for MDD, which should inform clinical care.
- |||||||||| Psychiatry and Prolactin—a Review of Literature () - May 5, 2022 - Abstract #APA2022APA_1023;
The ranking in order of Hyperprolactinemia presented by these authors: Paliperidone > Risperidone > Lurasidone > Ziprasidone > Iloperidone > Olanzapine > Asenapine > Placebo > Quetiapine > Aripiprazole...Cabergoline is preferable to Bromocriptine...Another type of treatment: Alternative and symptomatic management can also be attempted. Estrogens or testosterone for hypogonadism and/or decreased BMD, PDE5 inhibitors for erectile dysfunction, promoting healthy diet and physical exercise, avoiding tobacco and alcohol, for amenorrhea>6 months OCPs can be given to prevent osteoporosis, If low Vitamin D levels, then supplementation etc Psychiatrists need to work corroboratively with other specialties of Medicine and keep abreast of recent evidence base to manage this problem.
- |||||||||| sertraline / Generic mfg.
Sertraline Overdose Induced Mania in Adolescent: A Case Report () - May 5, 2022 - Abstract #APA2022APA_636; Younger individuals and those with a family history of mania are considered high risk 3 . It is imperative that clinicians are aware of the development of mania in such patients in the setting of sertraline overdose, regardless of the dose.
- |||||||||| clozapine / Generic mfg.
Refractory Mania Post-COVID-19 Infection Responsive to Clozapine () - May 5, 2022 - Abstract #APA2022APA_623; Background: Currently, there is robust evidence for the treatment of mania with lithium, valproate, carbamazepine and seven FDA approved antipsychotic medications: aripiprazole, asenapine, cariprazine, olanzapine, quetiapine, risperidone, and ziprasidone (1). There is also evidence for the use of clozapine and electroconvulsive therapy for treatment-refractory mania Speaker(s) Poster Presenter Emma Charlotte Cooper, MD View Profile Co-Author Vedang S. Uttarwar, MD View Profile Co-Author Alexis Seegan, MD View Profile
- |||||||||| lorazepam / Generic mfg., quetiapine / Generic mfg., ziprasidone / Generic mfg.
Management of Acute Mania in Patients With COVID-19 on Medical Floors: Pearls and Pitfalls () - May 5, 2022 - Abstract #APA2022APA_539; Conclusion Managing patients with acute mania on medical floors is difficult under normal circumstances, and if that patient has COVID-19, the balance of appropriately treating the patient for their psychiatric condition while mitigating risk of infection of others becomes even more precarious. We propose utilizing rational aggressive polypharmacy when managing acute manic patients with COVID 19 on medical floors.
|